Loading...
XNAS
ALGN
Market cap12bUSD
Apr 11, Last price  
164.14USD
1D
2.50%
1Q
-22.62%
Jan 2017
70.75%
Name

Align Technology Inc

Chart & Performance

D1W1MN
P/E
28.52
P/S
3.00
EPS
5.76
Div Yield, %
Shrs. gr., 5y
-1.31%
Rev. gr., 5y
10.69%
Revenues
4.00b
+3.54%
207,125,000206,354,000284,332,000303,976,000312,333,000387,126,000479,741,000560,041,000660,206,000761,653,000845,486,0001,079,874,0001,473,413,0001,966,492,0002,406,796,0002,471,941,0003,952,584,0003,734,635,0003,862,260,0003,999,012,000
Net income
421m
-5.32%
1,413,000-34,963,00035,724,00079,987,000-31,269,00074,253,00066,716,00058,691,00064,295,000145,832,000144,020,000189,682,000231,418,000400,235,000442,776,0001,775,888,000772,020,000361,573,000445,053,000421,362,000
CFO
738m
-6.05%
16,088,000-14,030,00052,777,00039,746,00074,165,000129,529,000130,469,000133,778,000185,976,000226,899,000237,997,000247,654,000438,539,000554,681,000747,270,000662,174,0001,172,544,000568,732,000785,776,000738,231,000
Earnings
Apr 22, 2025

Profile

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
IPO date
Jan 26, 2001
Employees
22,910
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,999,012
3.54%
3,862,260
3.42%
3,734,635
-5.51%
Cost of revenue
1,564,055
1,502,227
1,406,118
Unusual Expense (Income)
NOPBT
2,434,957
2,360,033
2,328,517
NOPBT Margin
60.89%
61.10%
62.35%
Operating Taxes
187,597
196,151
237,484
Tax Rate
7.70%
8.31%
10.20%
NOPAT
2,247,360
2,163,882
2,091,033
Net income
421,362
-5.32%
445,053
23.09%
361,573
-53.17%
Dividends
Dividend yield
Proceeds from repurchase of equity
(327,597)
(565,765)
(408,887)
BB yield
2.10%
2.70%
2.47%
Debt
Debt current
29,651
26,574
Long-term debt
176,428
193,936
200,668
Deferred revenue
160,662
Other long-term liabilities
236,374
289,809
320,368
Net debt
(867,459)
(757,177)
(814,320)
Cash flow
Cash from operating activities
738,231
785,776
568,732
CAPEX
(115,580)
(177,716)
(291,900)
Cash from investing activities
(254,912)
(195,943)
(213,316)
Cash from financing activities
(355,722)
(598,340)
(501,686)
FCF
2,271,712
2,105,755
1,943,481
Balance
Cash
1,043,887
972,742
999,584
Long term investments
8,022
41,978
Excess cash
843,936
787,651
854,830
Stockholders' equity
2,489,751
2,468,349
2,556,412
Invested Capital
3,332,637
3,259,266
3,280,143
ROIC
68.19%
66.18%
66.12%
ROCE
58.30%
58.32%
58.59%
EV
Common stock shares outstanding
74,993
76,568
78,420
Price
208.51
-23.90%
274.00
29.92%
210.90
-67.91%
Market cap
15,636,790
-25.47%
20,979,632
26.85%
16,538,778
-68.41%
EV
14,769,331
20,222,455
15,724,458
EBITDA
2,579,991
2,502,434
2,454,310
EV/EBITDA
5.72
8.08
6.41
Interest
5,367
Interest/NOPBT
0.23%